PE-VC investments in pharma grow 38% in H1

Ahmedabad: Private equity and venture capital (PE-VC) investments in the pharmaceutical sector have grown at 38 per cent year-on-year between January-June 2017, due to major deals ...

Indian pharma poised for US acquisitions

Mumbai: Indian pharmaceutical companies  are expected to make some key acquisitions in the US market in the short to medium term. "Indian companies are big participants a...

Indian pharma gets US FDA booster dose

Mumbai: The total abbreviated new drug application (ANDA) approvals given to Indian pharmaceutical companies by the US Food and Drug Administration (FDA) rose 45 per cent year-on-y...

Indian Pharma exports to USA may go up in 2017-18: Report

Hyderabad: The exports of Indian pharmaceutical industry to the US will get a boost in FY18, as branded drugs worth US$ 50 billion will become off-patented, according to a report b...

Samsung Biologics to manufacture Sun Pharma's new psoriasis drug

Mumbai: Sun Pharmaceutical Industries Ltd has entered into a long-term agreement worth US$ 55.5 million with South Korean company, Samsung Biologics, for manufacturing Tildrakizuma...

Telangana government to set up medical devices park, pharma city

Hyderabad: The Government of Telangana is planning to set up a medical devices park as well as a pharma city to facilitate the expansion of the existing pharmaceutical and drug man...

Lupin gets USFDA nod for opioid analgesic tablets

New Delhi: Lupin Limited, a pharmaceutical company, has obtained its final approval from US Food and Drug Administration (USFDA) for its Oxycodone Hydrochloride tablets, which is u...

Sun Pharma receives USFDA nod for anti-cholesterol drug

New Delhi: Sun Pharmaceutical Industries has obtained the final approval from the US Food and Drug Administration (USFDA) for its generic version of ezetimibe tablets, which is used to reduce high ...